This is an aggregated industry headline. Read the full story at AJMC →
Tags
theweekformat:headlineheadlineAJMC
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
The FDA is going forward with an investigation into the safety of the abortion pill mifepristone, an initiativ…
The WeekFierceBiotech ↗
Roche is paying Nurix Therapeutics $700 million upfront for rights to bexobrutideg, securing a stake in a BTK …
The WeekBriefing
Over half of eligible Medicare beneficiaries are now in Medicare Advantage, with growth concentrated in specia…